Viridian Therapeutics, Inc.\DE (VRDN) Gross Profit (2013 - 2016)
Viridian Therapeutics, Inc.\DE (VRDN) posted quarterly Gross Profit of -$183000.0 for Q4 2016, down 190.15% year-over-year from $203000.0 in Q1 2016, and down 154.3% quarter-over-quarter from $337000.0 in Q3 2016.
Viridian Therapeutics, Inc.\DE (VRDN) Gross Profit (2013 - 2016) Analysis & Trends
Viridian Therapeutics, Inc.\DE's Gross Profit history runs 4 years deep, the most recent figure standing at -$183000.0 for Q4 2016.
- In Q4 2016, Gross Profit fell 190.15% year-over-year to -$183000.0; the TTM figure through Dec 2016 stood at $929000.0 (up 2.99% YoY), while the FY2016 annual figure was -$1.9 million, down 2956.06% from the prior year.
- Gross Profit for Q4 2016 stood at -$183000.0, down from $337000.0 in the prior quarter.
- The five-year high for Gross Profit was $972000.0 in Q3 2014, with the low at -$183000.0 in Q4 2016.
- The 4-year median for Gross Profit is $348500.0 (2014), against an average of $361649.1.
- Peak annual rise in Gross Profit reached 769.64% in 2016, while the deepest fall reached 190.15% in 2016.
- Viridian Therapeutics, Inc.\DE's Gross Profit stood at $723157.0 in 2013, then tumbled by 117.42% to -$126000.0 in 2014, then surged by 261.11% to $203000.0 in 2015, then sank by 190.15% to -$183000.0 in 2016.
- Business Quant data shows VRDN's Gross Profit at -$183000.0 in Q4 2016, $337000.0 in Q3 2016, and $487000.0 in Q2 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Viridian Therapeutics, Inc.\DE | 2.50 Bn | 2.50 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | -183,000.00 |
| Dec 31, 2016 | -183,000.00 |
| Sep 30, 2016 | 337,000.00 |
| Sep 30, 2016 | 337,000.00 |
| Jun 30, 2016 | 487,000.00 |
| Jun 30, 2016 | 487,000.00 |
| Mar 31, 2016 | 288,000.00 |
| Mar 31, 2016 | 288,000.00 |
| Dec 31, 2015 | 203,000.00 |
| Dec 31, 2015 | 203,000.00 |
| Sep 30, 2015 | 758,000.00 |
| Sep 30, 2015 | 758,000.00 |
| Jun 30, 2015 | 56,000.00 |
| Jun 30, 2015 | 56,000.00 |
| Mar 31, 2015 | -115,000.00 |
| Mar 31, 2015 | -115,000.00 |
| Dec 31, 2014 | -126,000.00 |
| Dec 31, 2014 | -126,000.00 |
| Sep 30, 2014 | 972,000.00 |
| Sep 30, 2014 | 972,000.00 |